Glycoprotein IIb/IIIa Inhibitors May Modulate the Clinical Benefit of Radial Access as Compared to Femoral Access in Primary Percutaneous Coronary Intervention: A Meta-Regression and Meta-Analysis of Randomized Trials

Glycoprotein IIb/IIIa Inhibitors May Modulate the Clinical Benefit of Radial Access as Compared to Femoral Access in Primary Percutaneous Coronary Intervention: A Meta-Regression and Meta-Analysis of Randomized Trials

Objectives. Several randomized controlled trials (RCTs) consistently reported better clinical outcomes with radial as compared to femoral access for primary percutaneous coronary intervention (PCI). Nevertheless, heterogeneous use of potent antiplatelet drugs, such as Gp IIb/IIIa inhibitors (GPI), a...

Full description

Bibliographic Details
Main Authors: Stefano Rigattieri, Ernesto Cristiano, Francesca Giovannelli, Antonella Tommasino, Francesco Cava, Barbara Citoni, Domenico Maria Zardi, Andrea Berni, Massimo Volpe
Format: Article
Language:English
Published: Hindawi-Wiley 2021-01-01
Series:Journal of Interventional Cardiology
Online Access:http://dx.doi.org/10.1155/2021/9917407

Internet

http://dx.doi.org/10.1155/2021/9917407

Similar Items